142 related articles for article (PubMed ID: 28974603)
41. [A case of myasthenia gravis accompanied by large thymoma and anti-GAD antibody].
Kitae S; Kawakami H; Matsuoka N; Etoh R; Nakamura S
Rinsho Shinkeigaku; 2001 Nov; 41(11):818-21. PubMed ID: 12080617
[TBL] [Abstract][Full Text] [Related]
42. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
[TBL] [Abstract][Full Text] [Related]
43. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.
Cikrikçili U; Ulusoy C; Turan S; Yildiz S; Bilgiç B; Hanagasi H; Baykan B; Tüzün E; Gürvit H
Clin EEG Neurosci; 2013 Jul; 44(3):232-6. PubMed ID: 23820312
[TBL] [Abstract][Full Text] [Related]
44. [A case of progressive encephalomyelitis with rigidity and myoclonus associated with anti-GAD, anti-glycine receptor and anti-GM1 antibodies].
Koike Y; Suwabe T; Konno T; Umeda Y; Oyake M; Fujita N
Rinsho Shinkeigaku; 2015; 55(2):111-4. PubMed ID: 25746075
[TBL] [Abstract][Full Text] [Related]
45. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies.
Vulliemoz S; Vanini G; Truffert A; Chizzolini C; Seeck M
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):187-9. PubMed ID: 17229747
[TBL] [Abstract][Full Text] [Related]
46. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
[TBL] [Abstract][Full Text] [Related]
47. Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?
Lacruz Ballester L; Fernandez-Fournier M; Puertas Muñoz I; Rodriguez Fraga O; Lastras Fernandez-Escandon C; Rodriguez de Rivera Garrido FJ; Alba Suarez EM; Tallon Barranco A
Neurol Sci; 2022 Jan; 43(1):633-641. PubMed ID: 33914193
[TBL] [Abstract][Full Text] [Related]
48. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis.
Malter MP; Helmstaedter C; Urbach H; Vincent A; Bien CG
Ann Neurol; 2010 Apr; 67(4):470-8. PubMed ID: 20437582
[TBL] [Abstract][Full Text] [Related]
49. Anti-glutamic acid decarboxylase antibody positive neurological syndromes.
Tohid H
Neurosciences (Riyadh); 2016 Jul; 21(3):215-22. PubMed ID: 27356651
[TBL] [Abstract][Full Text] [Related]
50. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
51. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
52. [Autoantibody to glutamate decarboxylase in a patient with spinocerebellar degeneration and Sjögren syndrome].
Ikeda J; Harada T; Kamei H; Nakamura S
No To Shinkei; 1998 Feb; 50(2):177-80. PubMed ID: 9513208
[TBL] [Abstract][Full Text] [Related]
53. Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report.
Takagi M; Yamasaki H; Endo K; Yamada T; Kaneko K; Oka Y; Mori E
BMC Neurol; 2011 Dec; 11():156. PubMed ID: 22188660
[TBL] [Abstract][Full Text] [Related]
54. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
55. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
56. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
Kawasaki E; Abiru N; Yano M; Uotani S; Matsumoto K; Matsuo H; Yamasaki H; Yamamoto H; Yamaguchi Y; Akazawa S
J Autoimmun; 1995 Oct; 8(5):633-43. PubMed ID: 8579720
[TBL] [Abstract][Full Text] [Related]
57. [Usefulness of an anti-mouse cerebellar tissue-derived antigen antibody test in predicting immunotherapy efficacy in patients with idiopathic cerebellar ataxia].
Ohtomo T; Ogino S; Yanai S; Nakayama S; Yajima R; Sugawara M; Yamada J; Aizawa H; Taguchi T; Nanri K
Rinsho Shinkeigaku; 2022 Feb; 62(2):112-122. PubMed ID: 35095045
[TBL] [Abstract][Full Text] [Related]
58. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease.
Chang CC; Eggers SD; Johnson JK; Haman A; Miller BL; Geschwind MD
Clin Neurol Neurosurg; 2007 Jan; 109(1):54-7. PubMed ID: 16621241
[TBL] [Abstract][Full Text] [Related]
59. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
60. Case of Bickerstaff encephalitis with positive glutamic acid decarboxylase antibodies.
Javaid H; Ejaz U; Slowinski Z
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
